vimarsana.com

Latest Breaking News On - Aurobindo pharm - Page 1 : vimarsana.com

Top Gainers And Losers In Stock Market On Budget Day 2024

Top Gainers And Losers In Stock Market On Budget Day 2024
indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.

Nifty, Sensex Trending Higher - Weekly Closing Report

After the Bhartiya Janata Party s decisive victories in Chattisgarh, Rajasthan, and Madhya Pradesh last Sunday, the market witnessed a robust rally, which briefly paused mid-week. However, as the week concluded, buying momentum resumed, propelling benchmark indices to fresh highs. This resurgence was attributed to positive global cues and the Reserve Bank of India s (RBI) optimistic revision of the FY23-24 GDP forecast to 7%, up from the earlier 6.5%, in its monetary policy announcement.

Is Pharma back on growth track? Here s why Axis Securities is betting on Lupin, Cipla and Aurobindo Pharma

Axis Securities is betting on Lupin, Cipla and Aurobindo Pharma with up to 19 per cent upside potential.

investments: Next big delta in pharma to come from biosimilars: Nithya Balasubramanian

“For Aurobindo Pharma, our official rating is market performance. We do not recommend it from a long-term perspective. It is only a tactical recommendation for the next couple of quarters for the reasons that you just read out. In the case of Gland Pharma, Bernstein sees operational leverage.”

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.